PanGen Biotech Inc. (KOSDAQ:222110)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,945.00
-45.00 (-0.90%)
At close: Mar 21, 2025, 3:30 PM KST
-22.73%
Market Cap 61.65B
Revenue (ttm) 14.67B
Net Income (ttm) 943.69M
Shares Out 12.90M
EPS (ttm) 82.00
PE Ratio 58.29
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,927
Average Volume 16,218
Open 4,990.00
Previous Close 4,990.00
Day's Range 4,870.00 - 5,000.00
52-Week Range 3,750.00 - 7,770.00
Beta 0.00
RSI 43.20
Earnings Date n/a

About PanGen Biotech

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 222110
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.